From: Predicting responsiveness to GLP-1 pathway drugs using real-world data
Age | Sex | NSAID usage | Number of subjects | Decrease in HbA1c (mean ± SD) | Bonferroni-Adjusted p-Value |
---|---|---|---|---|---|
Age < = 40 | Male | No | 183 | 0.78 ± 2.17 | 5.12E-1 |
Yes | 73 | 0.56 ± 2.42 | |||
Female | No | 301 | 0.28 ± 1.70 | 8E00-3 | |
Yes | 119 | 0.82 ± 1.72 | |||
Age > 40 | Male | No | 1639 | 0.58 ± 1.66 | 2.42E-1 |
Yes | 2050 | 0.50 ± 1.54 | |||
Female | No | 1767 | 0.52 ± 1.43 | 2.00E-3 | |
Yes | 1724 | 0.36 ± 1.45 |